FDA approves amgen's riabni (rituximab-arrx), a biosimilar to rituxan (rituximab). Amgen, Inc. (2024). Riabni [package insert]. View All
Rituxan package insert. South San Francisco, CA: Genentech Riabni package insert. Thousand Oaks, CA: Amgen, Inc; 2024 Dec. 7
Rituximab containing products: Riabni (rituximab Riabni Prescribing Information. Amgen Inc. One Rituxan Hycela [package insert]. South San
HCPCS Codes. Description. J9312. Injection, rituximab, (Rituxan) 10 MG Riabni (rituximab-arrx) [package insert]. Thousand Oaks, CA
Riabni), the third biosimilar version of Rituxan product and for all off-label uses of the reference product. package insert listed in the Indications and
Truxima [package insert]. North Wales, PA: Teva Pharmaceuticals USA, Inc.; June May 2024. 6. Riabni [package insert]. Thousand Oaks, CA
Ruxience [package insert]. New York, NY; Pfizer, Inc; October 2024. Accessed April 2024. 4. Riabni [package insert]. Thousand Oaks, CA
Package insert rituximab Genetech/Biogen Annual review; replaced abbreviations, added Riabni updated Riabni billing units, fixed formatting/
product and biosimilar products). REFERENCES. 1. Riabni [package insert]. Thousand Oaks, CA: Amgen, Inc.; June2024. Page 2. This policy applies to the
I would like to know more about this package. ^.^